clinical trial · NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
SchizophreniaNBI-1117568
brief summary
This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.
started
Jul 11, 2025
primary completion
Dec 1, 2031
completion
Dec 1, 2031
last updated
Jun 5, 2026
official title
A Global, Phase 3, Multicenter, Open-Label Study to Assess the Long-Term Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol